Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00476788 · ClinicalTrials.gov registry record · NA
Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00476788 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 14 participants.
The verdict
NCT00476788, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study evaluates early initiation of continuous subcutaneous insulin infusion (CSII) therapy in young children using a novel delivery method in the form of a self-contained, lightweight, and disposable insulin pump unit controlled with a wireless handheld device. The outcomes of interest are the feasibility and potential metabolic benefits of this approach. We anticipate that the initiation of this CSII device in the immediate post-diagnosis period in this population will result in good glycemic control and greater parental satisfaction when compared to intensive insulin injection therapy.
Interventions
- DEVICE Omnipod Insulin Management System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00476788
The ClinicalTrials.gov registry entry for NCT00476788 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omnipod Insulin Management System is the first listed.
NCT00476788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00476788 about?
NCT00476788 is a clinical study titled "Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM". This study evaluates early initiation of continuous subcutaneous insulin infusion (CSII) therapy in young children using a novel delivery method in the form of a self-contained, lightweight, and disposable insulin pump unit controlled with a wireless handheld device. The outcomes of interest are the...
What is the current status of trial NCT00476788?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2007-04. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00476788?
The interventions under investigation include: Omnipod Insulin Management System (DEVICE).
Who is sponsoring clinical trial NCT00476788?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.